← Back to headlines
BioNTech Shares Rally on Moderna’s Oncology Breakthrough
BioNTech stock climbed as investors reacted positively to Moderna’s successful oncology developments, raising questions about whether competitor success validates BioNTech’s own cancer pipeline.
27 Aug, 21:52 — 27 Aug, 21:52
Sources
Showing 1 of 1 sources
Related Stories
Oil Prices Jump on US-Iran Strikes as Stocks Fall on Rate Hike Bets
28m ago
ONEOK Finalizes $4.43 Billion Acquisition of Brazos Midstream’s Permian Basin Assets
1h ago
China Manufacturing Activity Contracts for Second Consecutive Month
2h ago
Bessent Says Recent Yen Fluctuations Are Contained and Not Disorderly
2h ago